These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23860775)

  • 1. MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency.
    Ren J; Jin F; Yu Z; Zhao L; Wang L; Bai X; Zhao H; Yao W; Mi X; Wang E; Olopade OI; Wei M
    Tumour Biol; 2013 Dec; 34(6):3945-58. PubMed ID: 23860775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer.
    Jacot W; Thezenas S; Senal R; Viglianti C; Laberenne AC; Lopez-Crapez E; Bibeau F; Bleuse JP; Romieu G; Lamy PJ
    BMC Cancer; 2013 Nov; 13():523. PubMed ID: 24191908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer.
    Hsu NC; Huang YF; Yokoyama KK; Chu PY; Chen FM; Hou MF
    PLoS One; 2013; 8(2):e56256. PubMed ID: 23405268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression.
    Bal A; Verma S; Joshi K; Singla A; Thakur R; Arora S; Singh G
    Virchows Arch; 2012 Sep; 461(3):305-12. PubMed ID: 22820987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter Hypermethylation and Expression Changes of BRCA1 Gene in a Cohort of Sporadic Breast Cancer Cases among Pakistani Population.
    Arif T; Anwar N
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2395-2401. PubMed ID: 32856871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC is amplified in BRCA1-associated breast cancers.
    Grushko TA; Dignam JJ; Das S; Blackwood AM; Perou CM; Ridderstråle KK; Anderson KN; Wei MJ; Adams AJ; Hagos FG; Sveen L; Lynch HT; Weber BL; Olopade OI
    Clin Cancer Res; 2004 Jan; 10(2):499-507. PubMed ID: 14760071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
    Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
    Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer.
    Chen Y; Zhou J; Xu Y; Li Z; Wen X; Yao L; Xie Y; Deng D
    Cancer Sci; 2009 Sep; 100(9):1663-7. PubMed ID: 19522853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis.
    Yu Z; Xiao Q; Zhao L; Ren J; Bai X; Sun M; Wu H; Liu X; Song Z; Yan Y; Mi X; Wang E; Jin F; Wei M
    Mol Carcinog; 2015 Sep; 54(9):707-19. PubMed ID: 24464625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer.
    Stefansson OA; Jonasson JG; Olafsdottir K; Hilmarsdottir H; Olafsdottir G; Esteller M; Johannsson OT; Eyfjord JE
    Epigenetics; 2011 May; 6(5):638-49. PubMed ID: 21593597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
    Chen Y; Wang Y; Salas LA; Miller TW; Mark K; Marotti JD; Kettenbach AN; Cheng C; Christensen BC
    Breast Cancer Res; 2019 Jan; 21(1):14. PubMed ID: 30683142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy.
    Xu Y; Diao L; Chen Y; Liu Y; Wang C; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Deng D; Narod SA; Xie Y
    Ann Oncol; 2013 Jun; 24(6):1498-505. PubMed ID: 23406733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of BRCA1 promoter hypermethylation in Thai breast cancer patients.
    Saelee P; Chaiwerawattana A; Ogawa K; Cho YM; Tiwawech D; Suktangman V
    Asian Pac J Cancer Prev; 2014; 15(24):10585-9. PubMed ID: 25605143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
    Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
    Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
    Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
    Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer patients with hypermethylation in the promoter of BRCA1 gene exhibit favorable clinical status.
    Krasteva ME; Bozhanov SS; Antov GG; Gospodinova ZI; Angelov SG
    Neoplasma; 2012; 59(1):85-91. PubMed ID: 22103901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
    Wei M; Grushko TA; Dignam J; Hagos F; Nanda R; Sveen L; Xu J; Fackenthal J; Tretiakova M; Das S; Olopade OI
    Cancer Res; 2005 Dec; 65(23):10692-9. PubMed ID: 16322213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer.
    Bozhanov SS; Angelova SG; Krasteva ME; Markov TL; Christova SL; Gavrilov IG; Georgieva EI
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1657-69. PubMed ID: 20177704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.
    Joosse SA; Brandwijk KI; Mulder L; Wesseling J; Hannemann J; Nederlof PM
    Genes Chromosomes Cancer; 2011 Feb; 50(2):71-81. PubMed ID: 21104783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients.
    Sharma G; Mirza S; Yang YH; Parshad R; Hazrah P; Datta Gupta S; Ralhan R
    Cell Oncol; 2009; 31(6):487-500. PubMed ID: 19940364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.